SUMMARY We report a patient with acrodermatitis enteropathica and a normal serum zinc level in whom the diagnosis was confirmed by plasma phospholipid fatty acid and a small bowel biopsy response to oral zinc therapy. Acrodermatitis enteropathica is a rare autosomal recessive condition of zinc deficiency characterised by chronic diarrhoea associated with failure to thrive, periorificial dermatitis and alopecia, susceptibility to infections and behavioural changes.' Diagnosis is usually established by reduced serum zinc levels (classical acrodermatitis enteropathica). Paneth 
percentile) and the length was 64 cm (25th percentile). Physical examination revealed an irritable infant with circumscribed perianal ulceration ( Fig. 1) , sparse fine hair and ridging of the nails. Stools were loose with muCus.
Intakes of Nutramigenc in hospital averaged 115 kcal/kg/day (3.1 g protein/kg/day, linoleic acid 18 cal%). Weight increased by only 50 g over a two week period of investigations.
Laboratory evaluation revealed a haemoglobin of 97 g/l. Iron status was marginally low (serum iron 4 Rsmol/l (normal [5] [6] [7] [8] [9] [10] [11] [12] [13] !lmol/l), iron binding capacity 54 limol/l (normal Rmol/l)). White immunoglobulins, anti-white cell antibodies, serum trypsinogen, faecal fat excretion as a percentage of intake, sweat chlorides and a chest radiograph.
Blood for preprandial plasma phospholipid composition (taken four to six hours from the previous feeding) revealed low values for linoleic acid and Fig. 1 Perianial rash before zinc therapy. for major long chain polyunsaturated metabolites (20:3n-6, 20:4n-6, 22:5n-3, 22:6n-3) (Table) .
Light microscopy of a small bowel biopsy revealed focal areas of villous shortening with mild crypt lengthening and a slight increase in mixed inflammatory cell infiltrate in the lamina propria. Electron microscopy revealed numerous pleomorphic filamentous inclusion bodies typical of acrodermatitis enteropathica in the cytoplasm of most of the Paneth cells' (Fig. 2a) .
Based on a tentative diagnosis of variant acrodermatitis enteropathica, treatment with zinc sulphate (30 mg elemental zinc per day) by mouth was started. The patient's mood improved within four days, the perianal rash disappeared by two weeks. By one month the patient had gained 400 g, was passing one semiformed stool on alternate days, and had normal scalp, hair and nails. Neutrophil counts became consistently normal. Serum alkaline phosphatase had risen to 358 U/1.
Preprandial plasma phospholipid essential fatty acids increased within five days of therapy to normal or high normal levels and the long chain metabolites further increased after one month of therapy (Table) . A follow up small bowel biopsy on the 32nd day of zinc therapy showed normal histology under light microscopy. On electron microscopy the cytoplasm of Paneth cells contained numerous structurally normal secretory granules with only occasional filamentous inclusions (Fig. 2b) .
Methods
Small bowel biopsies were obtained using a Crosby capsule from the fourth part of the duodenum under fluoroscopic control. Specimens for light and electron microscopy were processed using standard methods. Plasma zinc was measured using atomic absorption spectrophotometry.' Preprandial plasma phospholipid composition was determined by capillary gas liquid chromatography.6 Discussion Our patient presented with chronic diarrhoea, poor weight gain, irritability and perianal ulceration, together suggestive of a zinc deficiency state. The marked ultrastructural abnormalities of the small intestinal Paneth cells encouraged a trial of oral zinc supplements in the face of normal levels of serum zinc and alkaline phosphatase, parameters most commonly measured in the direct and indirect assessment of zinc status.
The clinical syndrome of acrodermatitis enteropathica results from an as yet uncertain defect in intestinal absorption of zinc.' A mucosal or pancreatic zinc binding ligand of abnormal affinity has been implicated. This Zinc deficiency is thought to be associated with a reduced enteral absorption of unsaturated fatty acids and an impaired desaturation of linoleic and alphalinoleic acids to their long chain metabolites." Our patient showed zinc responsive alterations in essential fatty acid metabolism (Table) as previously noted in classical acrodermatitis enteropathica.' The increase in serum levels of essential fatty acids and their long chain metabolites had begun after only five days of oral zinc supplementation, thus preceding improvement in many of the clinical signs and symptoms. A low availability of essential fatty acids may play a role in the pathogenesis of acrodermatitis enteropathicarelated symptoms such as eczematoid dermatitis and susceptibility to infections.
Defective neutrophil chemotaxis has been reported in acrodermatitis enteropathica," but the intermittent neutropenia observed in our patient before zinc therapy is an unexplained observation.
Acrodermatitis enteropathica with normal serum zinc levels has hitherto been diagnosed solely by persistence of typical symptoms without treatment and a clinical response to zinc therapy. 
